Telesis Bio Inc Share Price Today: Live Updates & Key Insights

Telesis Bio Inc share price today is $2.85, up -19.05%. The stock opened at $3.21 against the previous close of $3.99, with an intraday high of $3.6168 and low of $2.8556.

Telesis Bio Inc Share Price Chart

Telesis Bio Inc

us-stock
To Invest in {{usstockname}}
us-stock

Telesis Bio Inc Share Price Performance

$2.85 -0.1905(-19.05%) TBIO at 23 Mar 2026 03:26 PM Medical Devices
Lowest Today 2.8556
Highest Today 3.6168
Today’s Open 3.21
Prev. Close 3.99
52 Week High 21.06
52 Week Low 1.27
Day’s Range: Low 2.8556 High 3.6168
52-Week Range: Low 1.27 High 21.06
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -
3 year return -
5 year return -
10 year return -

Telesis Bio Inc Institutional Holdings

Telesis Bio Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Telesis Bio Inc Fundamentals

Market Cap 7.07 M

PB Ratio 1.1076

PE Ratio 0.0

Enterprise Value 62.89 M

Total Assets 70.41 M

Volume 1913748

Telesis Bio Inc Company Financials

Annual Revenue FY23:30001000 30.0M, FY22:27435000 27.4M, FY21:11043000 11.0M, FY20:6576000 6.6M, FY19:7804000 7.8M

Annual Profit FY23:18647000 18.6M, FY22:15595000 15.6M, FY21:4299000 4.3M, FY20:3625000 3.6M, FY19:7804000 7.8M

Annual Net worth FY23:-38169000 -38.2M, FY22:-48471000 -48.5M, FY21:-38958000 -39.0M, FY20:-18010000 -18.0M, FY19:-113293000 -113.3M

Quarterly Revenue Q2/2024:1550000 1.6M, Q1/2024:3440000 3.4M, Q4/2023:6977000 7.0M, Q3/2023:5564000 5.6M, Q2/2023:8652000 8.7M

Quarterly Profit Q2/2024:-1605000 -1.6M, Q1/2024:271000 0.3M, Q4/2023:4096000 4.1M, Q3/2023:2997000 3.0M, Q2/2023:5693000 5.7M

Quarterly Net worth Q2/2024:-12585000 -12.6M, Q1/2024:-8637000 -8.6M, Q4/2023:-17687000 -17.7M, Q3/2023:-10631000 -10.6M, Q2/2023:-8287000 -8.3M

About Telesis Bio Inc & investment objective

Company Information Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits, which contains building blocks and reagents, including proprietary Gibson assembly branded reagents for specific synthetic biology workflow applications. It also provides BioXp Select kits that offers to use non-telesis bio DNA while using the BioXp system to perform synthetic biology workflow applications, such as cloning, mRNA generation from plasmid, and cell free amplification; BioXp Next Generation Sequencing kits, which contains reagents to go from DNA or RNA to a sequencer-ready library; Benchtop reagents that contains the reagents to proceed specific synthetic biology workflow on the benchtop using products generated on the BioXp system; and custom Gibson short oligo ligation assembly enzymatic DNA synthesis solutions, which is designed to construct synthetic DNA, RNA, and proteins for development of mRNA-based vaccines, diagnostics, therapeutics, and personalized medicines. The company serves its products to government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as Codex DNA, Inc. and changed its name to Telesis Bio Inc. in November 2022. Telesis Bio, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Organisation Medical Devices

Employees 101

Industry Medical Devices

CEO Mr. Eric Esser

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Telesis Bio Inc FAQs

What is the share price of Telesis Bio Inc today?

The current share price of Telesis Bio Inc is $2.85.

Can I buy Telesis Bio Inc shares in India?

Yes, Indian investors can buy Telesis Bio Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Telesis Bio Inc shares in India?

You can easily invest in Telesis Bio Inc shares from India by:

Can I buy fractional shares of Telesis Bio Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Telesis Bio Inc?

Telesis Bio Inc has a market cap of $7.07 M.

In which sector does Telesis Bio Inc belong?

Telesis Bio Inc operates in the Medical Devices sector.

What documents are required to invest in Telesis Bio Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Telesis Bio Inc?

The PE ratio of Telesis Bio Inc is N/A and the PB ratio is 1.11.